ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

ClinicalTrials.gov ID: NCT00109564

Public ClinicalTrials.gov record NCT00109564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 1:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI)

Study identification

NCT ID
NCT00109564
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Targacept Inc.
Industry
Enrollment
174 participants

Conditions and interventions

Interventions

  • ispronicline (nicotinic acetylcholine receptor agonist) Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Not listed
Completion
Sep 30, 2005
Last update posted
Jul 17, 2008

2005

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Pivotal Research Center Mesa Arizona 85210
Pivotal Research Center Peoria Arizona 85381
Radiant Research Denver Colorado 80212
Neuropsychiatric Research Center of SW Florida Fort Meyers Florida 33912
Meridien Research Saint Petersberg Florida 33709
Meridien Research Tampa Florida 33609
Northlake Medical Research Center Decatur Georgia 30033
Hartford Research Florence Kentucky 41042
Berman Center Minneapolis Minnesota 55404
Radiant Research St Louis Missouri 63141
Kulynych Research Center Greensboro North Carolina 27408
Wake Forest University Winston-Salem North Carolina 27157
Radiant Research Philadelphia Philadelphia Pennsylvania 19115
Radiant Research San Antonio Texas 78229
Radiant Research Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00109564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2008 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00109564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →